Glioma peptide vaccine shows early hints of efficacy

Generally, childhood cancers can be fairly treatable. However, some brain cancers, such as malignant astrocytomas of the brainstem and cerebral hemispheres and multiply recurrent low-grade gliomas don't respond well to treatment and the outcomes are not good for the patient. Adult gliomas can be treated with immunotherapies, and a group from the University of Pittsburgh Cancer Institute decided to see how the approach would work in children.

Recent Posts

Glioma peptide vaccine shows early hints of efficacy

New molecular subset of pediatric liver cancer identified

Frozen testicular tissue still viable after two decades

Study identifies potential target for treating childhood blood cancer

RAI Treatment in DTC Survivors Associated With Increased Risk of Other Cancers

AYA cancer survivors at higher risk for death due to second primary cancers

Immunotherapy for kids: An option for childhood liver cancer?

Biological pathways found that drive genomic changes and bone metastasis in Ewing Sarcoma

Research reveals a therapeutic opportunity to prevent rhabdomyosarcoma recurrence

We may know why some childhood cancers resolve on their own

Study finds jumping 'junk' DNA is a novel cause of childhood brain cancer

Archive

Search By Tags